1. Home
  2. XTNT vs ELUT Comparison

XTNT vs ELUT Comparison

Compare XTNT & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xtant Medical Holdings Inc.

XTNT

Xtant Medical Holdings Inc.

HOLD

Current Price

$0.21

Market Cap

39.6M

Sector

Health Care

ML Signal

HOLD

Logo Elutia Inc.

ELUT

Elutia Inc.

SELL

Current Price

$0.90

Market Cap

35.6M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
XTNT
ELUT
Founded
N/A
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.6M
35.6M
IPO Year
2009
2020

Fundamental Metrics

Financial Performance
Metric
XTNT
ELUT
Price
$0.21
$0.90
Analyst Decision
Buy
Analyst Count
3
0
Target Price
★ $0.75
N/A
AVG Volume (30 Days)
★ 226.9K
63.0K
Earning Date
11-16-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
125.00
★ 146.77
EPS
★ N/A
N/A
Revenue
★ $53,337,000.00
$12,293,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$10.30
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.17
$0.50
52 Week High
$0.84
$1.39

Technical Indicators

Market Signals
Indicator
XTNT
ELUT
Relative Strength Index (RSI) 27.58 56.43
Support Level N/A $0.90
Resistance Level $0.47 $0.91
Average True Range (ATR) 0.03 0.08
MACD -0.01 0.00
Stochastic Oscillator 26.33 76.70

Price Performance

Historical Comparison
XTNT
ELUT

About XTNT Xtant Medical Holdings Inc.

Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.

About ELUT Elutia Inc.

Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.

Share on Social Networks: